United States · FDA National Drug Code directory
Ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0615-8630_c75d65dc-e756-4444-bb23-a92fbba7cb1d
- Product NDC
- 0615-8630
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ciprofloxacin Hydrochloride
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250327
- Source listing expiry
- 20271231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, FILM COATED in 1 BLISTER PACK (0615-8630-10) · 0615-8630-10
- 14 TABLET, FILM COATED in 1 BLISTER PACK (0615-8630-14) · 0615-8630-14
- 20 TABLET, FILM COATED in 1 BLISTER PACK (0615-8630-20) · 0615-8630-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →